Colorectal cancer is one of the most commonly diagnosed cancers. Treatment options have increased dramatically over the past 10 years, but those available remain unsatisfactory. Chemotherapy continues as the main treatment, with targeted monoclonal antibody therapies added to cytotoxic regimens for more advanced disease. Treatment is also evolving as new chemotherapy combinations are investigated and novel products are introduced.